CompletedPhase 3NCT01138657

Efficacy and Safety of Adalimumab in Patients With Active Uveitis

Studying Infectious panuveitis

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: AbbVie (prior sponsor, Abbott)
Principal Investigator: Andy Payne, PhD
AbbVie
Intervention: Adalimumab(biological)
Enrollment: 239 enrolled
Eligibility: 18 years · All sexes
Timeline: 2010 – 2014

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01138657 on ClinicalTrials.gov

← Back to all trials